467 related articles for article (PubMed ID: 27226369)
21. Abnormalities in stress proteins in prion diseases.
Tatzelt J; Voellmy R; Welch WJ
Cell Mol Neurobiol; 1998 Dec; 18(6):721-9. PubMed ID: 9876878
[TBL] [Abstract][Full Text] [Related]
22. Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice.
Supattapone S; Bosque P; Muramoto T; Wille H; Aagaard C; Peretz D; Nguyen HO; Heinrich C; Torchia M; Safar J; Cohen FE; DeArmond SJ; Prusiner SB; Scott M
Cell; 1999 Mar; 96(6):869-78. PubMed ID: 10102274
[TBL] [Abstract][Full Text] [Related]
23. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.
Donne DG; Viles JH; Groth D; Mehlhorn I; James TL; Cohen FE; Prusiner SB; Wright PE; Dyson HJ
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13452-7. PubMed ID: 9391046
[TBL] [Abstract][Full Text] [Related]
24. Murine scrapie-infected neurons in vivo release excess prion protein into the extracellular space.
Jeffrey M; Goodsir CM; Bruce ME; McBride PA; Fowler N; Scott JR
Neurosci Lett; 1994 Jun; 174(1):39-42. PubMed ID: 7970151
[TBL] [Abstract][Full Text] [Related]
25. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform.
James TL; Liu H; Ulyanov NB; Farr-Jones S; Zhang H; Donne DG; Kaneko K; Groth D; Mehlhorn I; Prusiner SB; Cohen FE
Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10086-91. PubMed ID: 9294167
[TBL] [Abstract][Full Text] [Related]
26. A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP.
Priola SA; Caughey B; Wehrly K; Chesebro B
J Biol Chem; 1995 Feb; 270(7):3299-305. PubMed ID: 7852415
[TBL] [Abstract][Full Text] [Related]
27. A transmembrane form of the prion protein in neurodegenerative disease.
Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
[TBL] [Abstract][Full Text] [Related]
28. Prion protein and species barriers in the transmissible spongiform encephalopathies.
Priola SA
Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
[TBL] [Abstract][Full Text] [Related]
29. Prion protein peptides induce alpha-helix to beta-sheet conformational transitions.
Nguyen J; Baldwin MA; Cohen FE; Prusiner SB
Biochemistry; 1995 Apr; 34(13):4186-92. PubMed ID: 7703230
[TBL] [Abstract][Full Text] [Related]
30. Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system.
Brandner S; Raeber A; Sailer A; Blättler T; Fischer M; Weissmann C; Aguzzi A
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13148-51. PubMed ID: 8917559
[TBL] [Abstract][Full Text] [Related]
31. On safari with PrP: prion diseases of animals.
Westaway D; Carlson GA; Prusiner SB
Trends Microbiol; 1995 Apr; 3(4):141-7. PubMed ID: 7613755
[TBL] [Abstract][Full Text] [Related]
32. Structure-function aspects of prion proteins.
Daggett V
Curr Opin Biotechnol; 1998 Aug; 9(4):359-65. PubMed ID: 9720262
[TBL] [Abstract][Full Text] [Related]
33. Abnormal properties of prion protein with insertional mutations in different cell types.
Priola SA; Chesebro B
J Biol Chem; 1998 May; 273(19):11980-5. PubMed ID: 9565627
[TBL] [Abstract][Full Text] [Related]
34. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
35. Theoretical studies of sequence effects on the conformational properties of a fragment of the prion protein: implications for scrapie formation.
Kazmirski SL; Alonso DO; Cohen FE; Prusiner SB; Daggett V
Chem Biol; 1995 May; 2(5):305-15. PubMed ID: 9383432
[TBL] [Abstract][Full Text] [Related]
36. Prion protein fragments spanning helix 1 and both strands of beta sheet (residues 125-170) show evidence for predominantly helical propensity by CD and NMR.
Sharman GJ; Kenward N; Williams HE; Landon M; Mayer RJ; Searle MS
Fold Des; 1998; 3(5):313-20. PubMed ID: 9806936
[TBL] [Abstract][Full Text] [Related]
37. Selective neuronal targeting in prion disease.
DeArmond SJ; Sánchez H; Yehiely F; Qiu Y; Ninchak-Casey A; Daggett V; Camerino AP; Cayetano J; Rogers M; Groth D; Torchia M; Tremblay P; Scott MR; Cohen FE; Prusiner SB
Neuron; 1997 Dec; 19(6):1337-48. PubMed ID: 9427256
[TBL] [Abstract][Full Text] [Related]
38. Strain-dependent role of copper in prion disease through binding to histidine residues in the N-terminal domain of prion protein.
Hara H; Miyata H; Chida J; Sakaguchi S
J Neurochem; 2023 Nov; 167(3):394-409. PubMed ID: 37777338
[TBL] [Abstract][Full Text] [Related]
39. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
[TBL] [Abstract][Full Text] [Related]
40. Prion protein gene variation among primates.
Schätzl HM; Da Costa M; Taylor L; Cohen FE; Prusiner SB
J Mol Biol; 1995 Jan; 245(4):362-74. PubMed ID: 7837269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
